Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Acerta Pharma BV
Scientific Title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Bendamustine and Rituximab (BR) Alone Versus in Combination With Acalabrutinib (ACP-196) in Subjects With Previously Untreated Mantle Cell Lymphoma